Emergent Biosolutions - 13 Year Stock Price History | EBS

Historical daily share price chart and data for Emergent Biosolutions since 2006 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Emergent Biosolutions as of February 22, 2019 is 63.33.
Emergent Biosolutions Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 62.6133 57.7000 66.1600 57.5400 63.3300 6.83%
2018 56.2235 47.9700 73.2400 44.4400 59.2800 27.57%
2017 34.9138 33.2300 47.7500 28.3000 46.4700 41.50%
2016 32.0599 35.6916 41.4356 24.6000 32.8400 -12.40%
2015 29.9068 25.2062 37.7437 24.5784 37.4907 46.93%
2014 22.3056 22.5075 26.3212 18.6657 25.5154 18.44%
2013 16.1497 15.8358 22.4419 12.2564 21.5424 43.33%
2012 14.1415 15.9295 17.1852 12.0971 15.0300 -4.75%
2011 19.1232 22.2826 23.4071 14.0742 15.7796 -28.22%
2010 15.9711 12.9404 22.3014 12.6125 21.9828 72.63%
2009 14.8789 23.5101 24.6065 9.0142 12.7343 -47.95%
2008 11.5790 4.7695 24.4659 4.6758 24.4659 416.01%
2007 9.7116 10.5885 15.9108 4.4134 4.7414 -54.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.319B $0.561B
Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Biogen (BIIB) United States $65.929B 12.77
Celgene (CELG) United States $63.373B 11.74
Vertex Pharmaceuticals (VRTX) United States $48.023B 64.33
Regeneron Pharmaceuticals (REGN) United States $46.170B 21.45
Illumina (ILMN) United States $44.429B 52.84
Alexion Pharmaceuticals (ALXN) United States $29.015B 17.98
Incyte (INCY) United States $17.925B 167.48
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Seattle Genetics (SGEN) United States $11.201B 0.00
Exact Sciences (EXAS) United States $10.278B 0.00
Sarepta Therapeutics (SRPT) United States $9.393B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.07
Alnylam Pharmaceuticals (ALNY) United States $8.262B 0.00
BeiGene (BGNE) Cayman Islands $8.259B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bio-Techne Corp (TECH) United States $7.316B 49.29
Bluebird Bio (BLUE) United States $7.298B 0.00
Moderna (MRNA) United States $6.553B 0.00
Exelixis (EXEL) United States $6.350B 14.85
Amarin (AMRN) Ireland $5.554B 0.00
Alkermes (ALKS) Ireland $5.204B 0.00
Galapagos (GLPG) Belgium $5.177B 0.00
Array BioPharma (ARRY) United States $5.056B 0.00
Guardant Health (GH) United States $4.324B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.034B 0.00
Allogene Therapeutics (ALLO) United States $3.728B 0.00
Horizon Pharma Public (HZNP) Ireland $3.611B 14.85
Blueprint Medicines (BPMC) United States $3.388B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.346B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.062B 0.00
Genomic Health (GHDX) United States $3.022B 78.93
Ascendis Pharma (ASND) Denmark $2.941B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.854B 0.00
Immunomedics (IMMU) United States $2.735B 0.00
China Biologic Products (CBPO) China $2.677B 19.06
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Reata Pharmaceuticals (RETA) United States $2.596B 0.00
Repligen (RGEN) United States $2.588B 80.82
Mirati Therapeutics (MRTX) United States $2.585B 0.00
Ligand Pharmaceuticals (LGND) United States $2.527B 18.15
Arena Pharmaceuticals (ARNA) United States $2.464B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 54.42
Myriad Genetics (MYGN) United States $2.343B 23.87
Akcea Therapeutics (AKCA) United States $2.343B 0.00
Amicus Therapeutics (FOLD) United States $2.099B 0.00
Insmed (INSM) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.999B 0.00
Acceleron Pharma (XLRN) United States $1.940B 0.00
Spark Therapeutics (ONCE) United States $1.921B 0.00
Atara Biotherapeutics (ATRA) United States $1.798B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.782B 0.00
Medicines (MDCO) United States $1.765B 0.00
MyoKardia (MYOK) United States $1.757B 0.00
AnaptysBio (ANAB) United States $1.740B 0.00
NeoGenomics (NEO) United States $1.724B 141.92
CRISPR Therapeutics AG (CRSP) Switzerland $1.660B 0.00
REGENXBIO (RGNX) United States $1.657B 22.23
Zai Lab Unsponsored ADR (ZLAB) China $1.637B 0.00
Allakos (ALLK) United States $1.530B 0.00
Innoviva (INVA) United States $1.482B 4.09
Myovant Sciences (MYOV) United Kingdom $1.479B 0.00
UniQure (QURE) Netherlands $1.467B 0.00
ALECTOR INC (ALEC) United States $1.430B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.363B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.342B 0.00
Cambrex (CBM) United States $1.286B 13.87
Clovis Oncology (CLVS) United States $1.278B 0.00
GOSSAMER BIO (GOSS) United States $1.273B 0.00
Lion Biotechnologies (IOVA) United States $1.218B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.115B 0.00
Audentes Therapeutics (BOLD) United States $1.110B 0.00
WAVE Life Sciences (WVE) Singapore $1.093B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.072B 43.32
Rubius Therapeutics (RUBY) United States $1.067B 0.00
Puma Biotechnology (PBYI) United States $1.020B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.011B 0.00
Coherus BioSciences (CHRS) United States $0.986B 0.00
Editas Medicine (EDIT) United States $0.983B 0.00
Epizyme (EPZM) United States $0.967B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Fate Therapeutics (FATE) United States $0.926B 0.00
Retrophin (RTRX) United States $0.864B 0.00
Sangamo Therapeutics (SGMO) United States $0.864B 0.00
Athenex (ATNX) United States $0.854B 0.00
Vericel (VCEL) United States $0.840B 0.00
CytomX Therapeutics (CTMX) United States $0.791B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.782B 0.00
Apellis Pharmaceuticals (APLS) United States $0.780B 0.00
InflaRx (IFRX) Germany $0.767B 0.00
Novavax (NVAX) United States $0.766B 0.00
G1 THERAPEUTICS (GTHX) United States $0.752B 0.00
Heska (HSKA) United States $0.751B 61.47
Intra-Cellular Therapies (ITCI) United States $0.733B 0.00
Principia Biopharma (PRNB) United States $0.724B 0.00
ANI Pharmaceuticals (ANIP) United States $0.721B 13.80
Cellectis (CLLS) France $0.715B 0.00
Arvinas (ARVN) United States $0.711B 0.00
Dynavax Technologies (DVAX) United States $0.689B 0.00
Revance Therapeutics (RVNC) United States $0.665B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.654B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.641B 0.00
Synthorx (THOR) United States $0.637B 0.00
Twist Bioscience (TWST) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.627B 0.00
Acorda Therapeutics (ACOR) United States $0.623B 8.09
Intellia Therapeutics (NTLA) United States $0.604B 0.00
RA PHARMCTL INC (RARX) United States $0.601B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Kura Oncology (KURA) United States $0.572B 0.00
Anika Therapeutics (ANIK) United States $0.569B 23.56
Eidos Therapeutics (EIDX) United States $0.567B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Osiris Therapeutics (OSIR) United States $0.554B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.550B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Arcus Biosciences (RCUS) United States $0.516B 0.00
PDL BioPharma (PDLI) United States $0.511B 8.33
DBV Technologies (DBVT) France $0.493B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.492B 0.00
Zymeworks (ZYME) Canada $0.482B 0.00
UNITY Biotechnology (UBX) $0.477B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.476B 0.00
Senesco Technologies (ELOX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.455B 0.00
Zealand Pharma (ZEAL) Denmark $0.453B 5.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
BeyondSpring (BYSI) United States $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.439B 0.00
Replimune (REPL) United States $0.437B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
Kezar Life Sciences (KZR) United States $0.403B 0.00
Cytokineticsorporated (CYTK) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.401B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.398B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.387B 0.00
OSMOTICA PHARM (OSMT) United States $0.375B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.371B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Kindred Biosciences (KIN) United States $0.364B 0.00
MediciNova (MNOV) United States $0.362B 0.00
AVROBIO (AVRO) United States $0.360B 0.00
Agenus (AGEN) United States $0.359B 0.00
Inovio Pharmaceuticals (INO) United States $0.358B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.340B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.327B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
Evelo Biosciences (EVLO) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Solid Biosciences (SLDB) United States $0.309B 0.00
Cellular Biomedicine (CBMG) United States $0.308B 0.00
Aduro Biotech (ADRO) United States $0.307B 0.00
XBiotech (XBIT) United States $0.306B 0.00
Magenta Therapeutics (MGTA) United States $0.305B 0.00
Intec Pharma (NTEC) Israel $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.291B 0.00
Constellation Pharmaceuticals (CNST) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Kala Pharmaceuticals (KALA) United States $0.280B 0.00
AC Immune SA (ACIU) Switzerland $0.277B 0.00
Geron (GERN) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Axsome Therapeutics (AXSM) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Merus (MRUS) Netherlands $0.254B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.252B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Synlogic (SYBX) United States $0.242B 0.00
Seres Therapeutics (MCRB) United States $0.241B 0.00
Celcuity (CELC) United States $0.240B 0.00
Kamada (KMDA) Israel $0.236B 10.64
MannKind (MNKD) United States $0.235B 0.00
Verastem (VSTM) United States $0.231B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Cerecor (CERC) United States $0.211B 0.00
Athersys (ATHX) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.207B 0.00
Syros Pharmaceuticals (SYRS) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.201B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.199B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Aptinyx (APTX) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.185B 0.00
Axovant Sciences (AXGT) United Kingdom $0.184B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.163B 80.19
Mersana Therapeutics (MRSN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Proteostasis Therapeutics (PTI) United States $0.148B 0.00
BioTime (BTX) United States $0.146B 0.00
OvaScience (MLND) United States $0.142B 0.00
Allena Pharmaceuticals (ALNA) United States $0.133B 0.00
BioXcel Therapeutics (BTAI) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.129B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Cue Biopharma (CUE) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.127B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Unum Therapeutics (UMRX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Trevena (TRVN) United States $0.117B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
VolitionRX (VNRX) Singapore $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Chiasma (CHMA) United States $0.097B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
NantKwest (NK) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.66
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Celldex Therapeutics (CLDX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Eyenovia (EYEN) United States $0.057B 0.00
ARAVIVE, INC (ARAV) United States $0.057B 4.98
Proteon Therapeutics (PRTO) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
VIVUS (VVUS) United States $0.056B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
OVID THERAPEUTC (OVID) United States $0.046B 0.00
Selecta Biosciences (SELB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
VistaGen Therapeutics (VTGN) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Curis (CRIS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Arsanis (ASNS) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
AZURRX BIOPHARM (AZRX) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 5.08
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (GTXI) United States $0.021B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
IBio (IBIO) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.63
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00